Farmaceuticos Comunitarios最新文献

In 2025, which marks the 25th anniversary of our scientific society, SEFAC will be celebrating its national conference under the slogan 'Community pharmacy as a health, scientific and specialised profession', which attempts to encapsulate the essence of this period of transformation for the profession. Embracing change is not just an option but a necessity to ensure a solid and recognised future. As part of the 15th Conference, the professional debate 'Speciality in community pharmacy: a necessity?' will be held, which will serve to reflect on the path towards the consolidation of a specialisation that legitimises and further enhances the role of the community pharmacist within the healthcare system.

Introduction: Cardiovascular disease remains the leading cause of death. Arterial hypertension is the main avoidable risk factor. Scientific societies advise control methods such as Ambulatory Blood Pressure Monitoring (ABPM) but this technique is not usually available in rural settings.The aim of this study was to evaluate the effectiveness of pharmaceutical intervention using ABPM in community pharmacies.

Material and method: Observational study conducted in a rural community pharmacy between July 2021 and December 2023. Patients over 18 years of age who were normotensive or had a previous diagnosis of hypertension were selected. They were fitted with a MicrolifeWatch BP03 device for 29 hours. Patients with results compatible with HT were referred to their primary care physician.

Results: Twenty-one patients were included, of whom 20 were referred to the physician and treatment adjustments were made. Patient satisfaction was high, highlighting the accessibility of the service in the community pharmacy.

Conclusion: The accessibility and proximity of community pharmacies, especially in rural areas, facilitates the application of MAPA, improving the control of HTN.

Professional identity is the way in which professionals define themselves in relation to their professional role, encompassing both their sense of identity and the expected behaviors associated with that role. The formation of this identity is a complex process that begins at the undergraduate level and continues throughout a pharmacist's professional career. Several different professional identities have been identified in the world of pharmacy, which may indicate a degree of ambiguity in the role expected of this professional and a lack of clear direction and characterization of what makes the pharmacist "unique", although it may also suggest a flexible and broad view of the pharmacist's role. For the clinical role promoted by the various professional organizations at the international level to become a reality, and for the profession to be re-professionalized, students need to build a solid identity, and this work must begin at the undergraduate level. With the publication of the recent Delegated Directive (EU) 2024/782, a window of opportunity has opened for both the university and the profession to discuss where the profession should go and, more specifically, what the professional role of the pharmacist should be.

Introduction: Skin cancer prevention is a public health priority due to its high incidence and potential to cause significant morbidity and mortality. This study evaluated the effectiveness of an early skin cancer detection program in a community pharmacy, utilizing advanced technologies and interdisciplinary collaboration.

Objectives: 1. Early detection of melanoma and non-melanoma skin cancer in patients visiting the community pharmacy. 2. Facilitate patient referral to a dermatologist through the pharmacy.

Material and methods: A cross-sectional observational study was conducted in a community pharmacy between June 2018 and September 2023. Adult patients concerned about skin lesions were included. After obtaining written informed consent, an interview was conducted, and photographs of the lesions were taken and electronically sent to a dermatology service for a preliminary diagnosis within 24-48 hours.

Results: A total of 41 patients were evaluated (51% men; 54% over 50 years old). Benign lesions were identified in 54% of cases, avoiding unnecessary consultations and optimizing health resources. 46% presented suspicious cancer lesions requiring detailed evaluation, with 63% of this group being over 60 years old. More than 85% of the preliminary diagnoses were accurate with the images sent.

Discussion: The results underscore the effectiveness of early detection programs in community pharmacies for identifying benign and suspicious lesions, optimizing resources, and facilitating early interventions. The collaboration between pharmacists and dermatologists, along with the use of advanced technologies, were key to the program's success. However, the study's limitations include the sample size and its focus on a single pharmacy.

Conclusions: Community pharmacies can play a crucial role in the secondary prevention of skin cancer, improving healthcare system efficiency and benefiting patients through early detection and timely intervention. Future studies with larger samples are recommended to validate these findings and quantify resource optimization.

A 73-year-old, dependent, polymedicated, multi-pathological patient contacts the Community Pharmacy by telephone to request information on a newly prescribed treatment for a urinary tract infection and vitamin D deficiency. The dispensing of the medication to her caregiver leads to further doubts for the patient, so she is offered the Medication Use Review (MUR) service. During the service, several incidences are detected in her treatment, so it is decided to make a referral report to the Primary Care Physician for a complete review of the treatment and thus be able to refer the patient to the Personalized Dosage System (SPD) service in order to guarantee the patient's pharmacotherapeutic safety and improve her adherence to the treatment. In this case, the provision of the RUM service served as a gateway to the SPD and made it possible to detect Medication Related Problems (MRP) that could lead to therapeutic failure.

Introduction: The medicines aid kits revision services is a Clinical Professional Pharmacy Service that aims to increase patients' knowledge about their medication, (What it is for, how to take it, how to preserve…). It also promotes proper management of expired and/or unused medicines, (disposal at punto SIGRE in pharmacies) to reduce their environmental impact.

Objective: To review the medicines, medical devices, and/or self-care products that the patient has at home, to record any incidents detected, and any pharmaceutical interventions carried out.

Material and methods: The campaign was open to all pharmacies in Alava. Participating pharmacies, after completing specific training, reviewed medicines aid kits and filled in an electronic form with the collected data. Finally, the data were analysed.

Results: The main pharmaceutical interventions were to dispose of expired medicines at point SIGRE, inform about appropriate use and storage at home.

Discussion: This study reinforces the role of the pharmacist within the health system as an indispensable agent in improving patient health.

Anticholinergic drugs are widely used for very common diseases such as Parkinson's disease, depression or allergies, but it has been observed in previous studies that high anticholinergic burden can lead to physical and cognitive dysfunctions in polymedicated elderly people. The objective of this project is to review these hypotheses and study the possible relationship between high anticholinergic burden and cognitive and physical dysfunctions.In terms of methodology, a bibliographic review has been carried out of the information that exists to date on the hypothesis that high anticholinergic burden can lead to both physical and cognitive dysfunctions in elderly people taking multiple medications, and a cross-sectional study has been designed that included patients over 70 years and taking multiple medications to calculate the anticholinergic burden of their medication and determine whether high levels of it could have any influence on the deterioration of the patients.At the end of the study, it was observed high prevalence of prescriptions of medications with high anticholinergic burden in elderly patients, with its consequences in terms of adverse effects. These results lead us to the conclusion of the need to take into account the anticholinergic burden of medications when prescribing.

If we want community pharmacy to be care-giving and integrated into the health system as a fundamental resource, we must demonstrate the evolution of professional pharmaceutical services and to do so, initiatives such as the Observatory of Professional Pharmaceutical Services (OBSERVAFARMA) that SEFAC has launched are necessary. It is underway and will see the light of day in 2025. This Observatory was born with the vocation to add and is open to the collaboration and participation of all agents in the health ecosystem.

Objective: To review and validate a questionnaire on knowledge of injectable insulin management (JH-SEFAC) by patients with diabetes for use in community pharmacies.

Methods: Study design: cross-sectional observational in Spanish community pharmacies during the first half of 2023. Inclusion criteria: patients with diabetes, of legal age, on insulin treatment. Questionnaire design: a nominal group of community pharmacists reviewed and piloted the initial questionnaire to determine its feasibility. It was approved by the CEIC of Aragón (PI22/375). Content validation: by a multidisciplinary group of experts in diabetes, using an ad hoc evaluation questionnaire of 10 questions (Likert scale of 1-5). Reliability: by means of the internal consistency index (Cronbach's alpha) and the intraclass correlation coefficient (ICC). Reproducibility (test/retest): the results of the questionnaire administered twice 2-3 weeks apart to the group of patients were compared. Pharmacists members of the SEFAC Diabetes Working Group collaborated. Sample: calculated in 127 subjects (95% CI and precision of 10%).

Results: 20 community pharmacies from 13 autonomous communities included 131 patients. The expert assessment was 4.52 out of 5 (90.4%). The Keiser-Meyer-Olkin test was 0.626 and Bartlett's test was significant (p<0.001). The Cronbach's alpha of the global questionnaire was 0.804 and the ICC was 0.902. The mean score of the questionnaire was 15.98 out of 31 points.

Conclusions: The JH-SEFAC questionnaire was validated to evaluate the management of insulin injectables, providing community pharmacists with a valuable tool for therapeutic education.

Case presentation: A 73-year-old woman, independent, with a medical history of psychopathology under treatment and non-compliant. After a fall, he suffered a forearm fracture and, in this context, abuse of psychoactive drugs and non-steroidal antiinflammatory drugs was suspected.

Study and evaluation of the case: The state of the patient's situation was evaluated, and an abuse of the hypnotic-anxiolytic treatment was observed, which could be related to her recent forearm fracture. His poor therapeutic adherence led to poor control of his health problems and the appearance of possible Negative Outcomes Associated with Medication (NOM).

Intervention: He was referred to his primary care physician with a pharmacist consultation report, indicating the possible NMRs and therapeutic alternatives in antihypertensive and antidepressant treatment.

Results: The family physician related the fall and subsequent forearm fracture, as well as the decompensation of his basal pathology, with therapeutic noncompliance. The proposal for pharmaceutical intervention was accepted, monitoring blood pressure for its corresponding dosage readjustment, bupropion was withdrawn, a gradual deprescription of benzodiazepine doses began, and the antiinflammatory was replaced by analgesics. Consequently, the patient significantly improved her cardiovascular health and her quality of life, in addition to increasing her personal autonomy.

Conclusions: Multidisciplinary communication between health professionals allows better control of cardiovascular disease and optimization of pharmacotherapy and health resources, contributing to improving their state of health.